Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study
Background: Chemotherapy plus granulocyte colony-stimulating factor (GCSF) regimen is one of the available approaches to mobilize peripheral blood progenitor cells (PBPCs). It causes thrombocytopenia and delays leukapheresis. This study aimed to evaluate the role of recombinant human thrombopoietin...
Guardado en:
Autores principales: | Hongnan Mo, Peng Liu, Yan Qin, Xiaohui He, Xiaohong Han, Jiarui Yao, Weicai Su, Shuxiang Zhang, Le Tang, Fengyi Zhao, Lin Gui, Sheng Yang, Jianliang Yang, Shengyu Zhou, Zhishang Zhang, Yuankai Shi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/279bea36891a4254ab4faafb9cb97354 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Thrombopoietin from hepatocytes promotes hematopoietic stem cell regeneration after myeloablation
por: Longfei Gao, et al.
Publicado: (2021) -
Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures
por: Robert Flisiak, et al.
Publicado: (2021) -
The pathophysiology of thrombocytopenia in chronic liver disease
por: Mitchell O, et al.
Publicado: (2016) -
Phase planning today
por: Knapp,Steve, et al.
Publicado: (2007) -
EVALUATION OF PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED HODGKIN’S LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT
por: Jhanzeb Iftikhar, et al.
Publicado: (2021)